JOHN NAZARIAN: Open Payments
NPI 1952311805 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 7 payments from 6 companies in 2025. Trend: 2023 $23,020 · 2024 $3,252 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $127 |
| ABBVIE INC. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $117 |
| Janssen Pharmaceuticals, Inc | 2 | $113 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, COBENFY, ERZOFRI EXTENDED-RELEASE.
Industry payments across CT — which companies pay providers there.
